Disclosures for "Characteristics of Real-world Patients With Chronic Inflammatory Demyelinating Polyradiculoneuropathy Initiating Subcutaneous Efgartigimod in United States "
-
Swapna Karkare has received personal compensation for serving as an employee of argenx. Swapna Karkare has stock in argenx.
-
Ms. Zaveri has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for Argenx. Ms. Zaveri has stock in Argenx . Ms. Zaveri has stock in Apellis. Ms. Zaveri has received personal compensation in the range of $100,000-$499,999 for serving as a Director, Medical Affairs with argenx.
-
Dr. Mahajerin has received personal compensation for serving as an employee of argenx. Dr. Mahajerin has stock in argenx.
-
Mr. Challa has nothing to disclose.
-
Dr. Zou has received personal compensation for serving as an employee of ZS Associates.
-
Dr. Sato has received personal compensation for serving as an employee of ZS Associates.
-
Dr. BLEIN has received personal compensation for serving as an employee of argenx. Dr. BLEIN has stock in argenx.